Bit Origin
BTOG
Bakkt Holdings
BKKT
Bitdeer Technologies
BTDR
SATO TECHNOLOGIES CORP
CCPUF
FRMO CORP
FRMO
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.